Gynecologic infection rates after ablation treatment for cervical intraepithelial neoplasia grade 2 and higher (CIN2+): Secondary analysis of a non-inferiority randomized trial

  • 0Department of Obstetrics, Gynecology and Reproductive Science, The Mount Sinai Hospital, New York, New York, United States of America.

|

|

Summary

This summary is machine-generated.

Cervical ablation treatments for precancer do not increase the risk of sexually transmitted infections (STI) or vaginitis. Non-gas cryotherapy and thermal ablation are safe alternatives to gas-based cryotherapy, with adherence to post-treatment care being crucial for preventing infections.

Area Of Science

  • Gynecology
  • Infectious Diseases
  • Public Health in Low- and Middle-Income Countries (LMIC)

Background

  • Concerns exist regarding infection risks associated with cervical precancer ablation treatments in LMICs.
  • Limited data currently substantiates these concerns.
  • Cervical intraepithelial neoplasia grade 2 or higher (CIN2+) requires effective and safe treatment options.

Purpose Of The Study

  • To evaluate the incidence of sexually transmitted infections (STI) and vaginitis following three different ablation treatments for CIN2+.
  • To compare the safety profiles of CO2 gas-based cryotherapy, non-gas cryotherapy, and thermal ablation (TA) regarding gynecologic infections.
  • To assess the impact of post-treatment adherence on infection rates.

Main Methods

  • Secondary analysis of a randomized non-inferiority trial (NCT03084081) involving 864 women with CIN2+.
  • Collection of samples at baseline and 6 weeks post-treatment to assess for STIs (Chlamydia trachomatis, Neisseria gonorrhea, Trichomonas vaginalis) and vaginitis (Bacterial vaginosis, Candida albicans).
  • Comparison of infection incidence across three ablation treatment arms and between adherent and non-adherent patient groups.

Main Results

  • None of the evaluated ablation treatments (CO2 gas-based cryotherapy, non-gas cryotherapy, TA) increased the risk of STIs or vaginitis.
  • The incidence of gynecologic infections did not significantly increase from baseline to 6-week follow-up across all treatment groups.
  • Women not adhering to post-treatment recommendations showed a higher incidence of STIs compared to those who adhered.

Conclusions

  • Cervical ablation treatments for CIN2+ are safe concerning STI and vaginitis incidence.
  • Non-gas cryotherapy and thermal ablation are safe alternatives to gas-based cryotherapy regarding gynecologic infection rates.
  • Adherence to post-treatment care is important for minimizing STI risk after cervical ablation.